整合历史和生活方式数据与脂水平,以进行基于风险的前列腺癌查
Caterina Peraldo-Neia1, Paola Ostano1, Melissa Savioli1
1Genomics Lab, Fondazione Edo ed Elvo Tempia, Biella, 13900, Italy.
Journal of translational medicine
|July 14, 2025
概括
将循环中的脂与PSA,生活方式和病史相结合,可以改善前列腺癌 (PCa) 检测. 这种方法提高了查准确度,并减少了对可疑PCa的不必要的侵入性测试.
科学领域:
- 在瘤学瘤学.
- 生物标志物发现发现
- 医学诊断 医学诊断 医学诊断
背景情况:
- 目前的前列腺癌 (PCa) 查依赖于PSA测试,这有局限性.
- 为了有效的PCa查,分层个体风险至关重要.
- 尽量减少不必要的二级调查是PCa诊断的一个关键目标.
研究的目的:
- 将历史记录,生活方式和循环脂数据与PSA水平相结合.
- 改进临床显著PCa (ISUP>1) 的检测.
- 减少对怀疑PCa.的男性进行侵入性和昂贵的调查的需要.
主要方法:
- 收集了904名男性的血样本,临床病史,PSA水平和生活方式数据.
- 使用了无变量和处罚的逻辑回归,并进行了10倍的交叉验证.
- 在369名男性的子集中使用质谱分析了50种脂体.
- 整合了各种数据类型,以构建PCa和ISUP>1PCa的预测模型.
主要成果:
- 与PSA与年龄,心血管疾病 (CVD) 和久坐改善了PCa检测的结合 (ROC-AUC 0.89).
- 综合脂,PSA,年龄和临床因素实现了高PCa分类准确性 (平均ROC-AUC为0.92).
- 特定的螺旋脂质 (例如,Cer-20,HexCer-20) 和临床因素 (例如,心血管疾病,年龄) 是PCa和临床显著PCa的关键预测因素.
结论:
- 循环中的脂体显示为PCa查的生物标志物具有前途.
- 将脂与PSA和临床/生活方式数据相结合,可以提高查精度.
- 这种综合方法有可能减少PCa诊断中不必要的侵入性手术的数量.
更多相关视频
相关概念视频
Chronic Pancreatitis II: Collaborative Care
563
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
563
Serum Laboratory Studies, Stool Test, Breath Test
1.2K
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.2K
Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863


